Profound Medical (PROF) Invested Capital (2018 - 2026)

Profound Medical has reported Invested Capital for 9 years, with the latest figure at $63.9 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 15.65% year-over-year to $63.9 million; the trailing twelve-month figure through Mar 2026 stood at $63.9 million (up 15.65% YoY), and the FY2025 full-year result was $70.9 million, up 8.99% from the prior year.
• Invested Capital for Q1 2026 stood at $63.9 million, down from $70.9 million in the prior quarter.
• The five-year high for Invested Capital was $74.5 billion in Q1 2022, with the low at $30.7 million in Q3 2024.
• Average Invested Capital over 5 years is $7.3 billion, with a median of $55.3 million recorded in 2025.
• Peak annual rise in Invested Capital reached 69.81% in 2024, while the deepest fall reached 99.91% in 2024.
• Tracing PROF's Invested Capital over 5 years: stood at $59.8 million in 2022, then sank by 35.88% to $38.3 million in 2023, then jumped by 69.81% to $65.1 million in 2024, then climbed by 8.99% to $70.9 million in 2025, then retreated by 9.88% to $63.9 million in 2026.
• The last three Invested Capital figures came in at $63.9 million (Q1 2026), $70.9 million (Q4 2025), and $36.6 million (Q3 2025), per Business Quant data.

Peer Comparison